Toxicity study of gemcitabine, oxaliplatin, and bevacizumab, followed by 5-fluorouracil, oxaliplatin, bevacizumab, and radiotherapy, in patients with locally advanced pancreatic cancer

Davendra P.S. Sohal, James M. Metz, Weijing Sun, Bruce J. Giantonio, John P. Plastaras, Gregory Ginsberg, Michael L. Kochman, Ursina R. Teitelbaum, Kathleen Harlacker, Daniel F. Heitjan, Michael D. Feldman, Jeffrey A. Drebin, Peter J. O'Dwyer

Research output: Contribution to journalArticlepeer-review

10 Scopus citations

Fingerprint

Dive into the research topics of 'Toxicity study of gemcitabine, oxaliplatin, and bevacizumab, followed by 5-fluorouracil, oxaliplatin, bevacizumab, and radiotherapy, in patients with locally advanced pancreatic cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds